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• Reliability, Variability, and Bias
• Diagnostic Testing and Measures of Association
Epidemiology and Biostatistics
• Evidence-Based Medicine




What is a study design?
• Framework, or set of methods 
and procedures, used to collect 
and analyze data on specific 
variables denoted by a research 
problem
• Types of design employed to 
answer different types of 
research questions






Counts, Ratios, Rates, and Proportions
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1. Count
• Simplest and most frequently performed 
quantitative measure
• Number of cases of a disease or health 
phenomenon
2. Ratio
• Division of one quantity by another (fraction!)
A. Proportions
• Ratio where numerator is part of denominator.
• May be expressed as a percentage (Proportion * 100%)
B. Rates (risk!)
• Ratio where time forms part of the denominator.
• Disease frequency, time period, population unit size
Incidence and Prevalence
• Incidence = new cases
• Rate of (# new cases) / (# people 
at risk in given time frame)
• Measuring how fast the disease is 
occurring = risk
• Prevalence = all cases (in total)
• Proportion (%) of (# cases) / (# 
total people)
• How much disease is in the 
population? = burden of disease
8
Validity and Reliability 
• Validity = degree measurement reaches correct conclusion 
• (1) Internal Validity
• Results accurately reflect true situation of study population, defined by boundaries of the study
• Provides a true estimate of effect, given the limits of the population studied 
• (2) External Validity
• Results are applicable to other populations (generalizability)
• Do these results apply to other patients, such as patients who are older, sicker, or less 
economically advantaged than subjects in the study?
• Reliability = degree to which an instrument can produce precise, 
consistent results, repeatedly over different occasions, with there 
is no evidence of change.
9
Bias
• Can be random or systematic
• Systematic error that leads to 
distortion of results
• Can occur anywhere; big 
concern in observational studies 
because of lack of 
randomization
• (3) categories of systematic bias




• Distortion because of how subjects are 
sampled/selected
• The selection process increases or 
decreases chance a relationship between 
exposure and outcome will be detected
• Volunteers may differ from non-volunteers
• Selecting participants based on referral to 
clinical facilities
• Potential disconnect with diagnosis and 
subsequent eligibility
• Hospitalized v. non-hospitalized patients  
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Bias (cont.)
2. Information Bias (aka misclassification)
• Distortion because of manner data are collected or classified
• Random or systematic inaccuracy of measurement 
• Investigator may assign correctly or incorrectly, leading to increase in true positives, true negatives, false 
positives, false negatives
• (2) Types:
• Nondifferential: errors in classification of exposure/disease that do not depend on the 
other variable; underestimates the true association
• Differential: errors in classification of exposure/disease that depends on the other 
variable; may over or underestimates the true association
• Recall bias: differential ability of subjects to remember previous activities and exposures




• Extraneous factors distorts true association 
being examined
• Mixing of the effect of an extraneous 
“lurking” variable with the effects of 
exposure and disease
• Confounding Requirements:
1. The confounding factor must be associated 
with the outcome
2. The confounding factor must be associated 
with the exposure
3. A confounder cannot be an intermediary 
step in the causal pathway from the 
exposure to the outcome 
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Determining Validity of a Clinical Test
• Descriptors of Test Accuracy
• Sensitivity (SNout)
• Proportion of persons with disease who test 
positive (a/a+c)
• Specificity (spIN)
• Proportion of healthy persons who test 
negative (d/d+b)
• Probability Estimates:
• Positive Predictive Value (PPV)
• Proportion of persons with positive test 
who actually have disease (a/a+b)
• Negative Predictive Value (NPV)
• Proportion of persons with negative test 







Measures of Association: Odds Ratio (OR)
• Odds that outcome will occur 
given exposure v. odds of outcome 
occurring in absence of exposure
• ratio of two odds 
• outcome exposed/outcomeunexposed
• What OR means…
• OR = 1.0: no difference
• OR > 1.0: increase in odds 
• OR < 1.0: decrease in odds
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The odds of lung cancer is 4.32 times greater 
among smokers compared to non-smokers. 
Measures of Association: Relative Risk (RR)
• Likelihood that an exposed group 
will  develop an outcome relative 
to those unexposed
• Compares the risk of a health event 
among one group with 
the risk among another group
• AKA “risk ratio” or “rate ratio”
• riskexposed/riskunexposed
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The risk of developing lung cancer is 2.54 
times greater among smokers compared to 
non-smokers.
Measures of Association: Hazard Ratio (HR)
• Measure of effect of intervention on 
outcome over time
• Reported as time-to-event analysis or 
survival analysis 
• Type of relative risk used to express 
treatment effects, determine how groups 
change relative to each other (faster/slower)
• Rate in which events happen in treatment 
v. control group as a function of time 
• hazardintervention / hazardcontrol
• Kaplan-Meier curves
• Relative event rate in the groups
• Y-Axis = prob. of survival (%); X-Axis = time




• Probability that observed result is due 
to chance alone
• “Is there a statistically significant 
difference between treatments/groups? 
• Interpretation based on cutoff/ level of 
significance (e.g. 0.05, 0.01)
• Observed association gives no 
indication about clinical importance
• Information from single sample will 




• Range of values for a measure that is believed to contain 
the true value; within specified certainty level 
• Estimation, magnitude and direction of difference 
• Range of values within which we are reasonably confident 
that the true association (OR, RR, HR = point estimate)
• E.g. OR = 2.5; 95%CI: 1.7 - 3.6
• Example: Imagine the study is repeated thousand times
• About 95% of time the different possible results obtained will 
lie in this interval. 
• Therefore, we say we are 95% confident that the true population 
value of what we are estimating in our study lies within the 
interval. 
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OR = 1.6 (95% CI: 1.2, 2.9)* 
OR = 0.22 (95% CI: 0.18, 0.33)* 
OR = 0.90 (95% CI: 0.20, 1.13) 
Population Health 
Evidence-Based Medicine
• Making health care decisions based on: 
• Current best evidence 
• Clinical expertise
• Pathophysiological knowledge
• Provide objective basis for selecting strategy 
for disease management
• Serve as basis for modifying practice
• Facilitates assessment
• Identifies gaps in knowledge
• Suggest opportunities for improved care quality 




Assessing and Evaluating Literature
• Evaluation of an individual study 
should include:
• Research hypothesis 
• Study design
• Variables
• Methods of analysis
• Sources of bias 
• Useful to apply a uniform and 
thorough approach to evaluating the 
articles
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STROBE: Strengthening the Reporting of Observational 
Studies in Epidemiology
•22-item checklist authors needs to fulfil before 
submitting manuscript
•Guidelines created to aid authors in ensuring high-
quality presentation of observational studies
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Clinical Decision-Making
• Understanding of the derivation, 
calculation, and use of probabilities 
is important in making clinical 
decisions
• Formal decision analysis = explicit 
process, uses information from 
epidemiologic studies to determine 
course of action
• Elements of formal decision analysis:
• 1. Decision tree diagram
• 2. Probabilities for uncertain events
• 3. Test results





















Collectively work together to 
improve the health and wellness of 
people, places, and communities 
References, Further Readings, and Additional Resources




• Incidence and Prevalence
• https://www.youtube.com/watch?v=1jzZe3ORdd8&feature=emb_title




























More questions, comments, or suggestions? 
Email: Allison.Casola@jefferson.edu | Twitter: @arcasola
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